prognostic indicators

Research in Review

Predictor of Aggressive Disease in Multiple Myeloma Identified

07/18/2017

JCP Editors

Certain patients with multiple myeloma often have poorer outcomes, according to a recent meta-analysis. ----- Related Content Circulating tumor cells may help guide bladder cancer treatment Plasma ghrelin levels...

...

07/18/2017

Journal of Clinical Pathways

Research in Review

Model Predicts Tumor Spread in Lung Cancer

07/17/2017

JCP Editors

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Prognostic Indicator Identified for Patients With DLBCL

07/14/2017

JCP Editors

Patients with diffuse large B-cell lymphoma (DLBCL) with a specific disease characteristic are expected to have poor clinical outcomes, according to research published in Leukemia (published online July 12, 2017;...

...

07/14/2017

Journal of Clinical Pathways

Research in Review

Blood Test Predicts Survival Outcomes in Patients With Type of Lung Cancer

07/11/2017

JCP Editors

A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...

A...

07/11/2017

Journal of Clinical Pathways

Research in Review

Neoadjuvant Chemotherapy May Induce Breast Cancer Metastasis

07/10/2017

JCP Editors

A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

Risk Stratification, Therapy Intensification Improves Prognosis in Adult ALL

06/29/2017

JCP Editors

Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...

Adult...

06/29/2017

Journal of Clinical Pathways

Research in Review

New Prognostic Model Accurately Predicts Survival in Lung Cancer With Brain Metastases

06/28/2017

JCP Editors

A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...

A new...

06/28/2017

Journal of Clinical Pathways

Research in Review

Novel Prognostic Biomarker Identified in DLBCL

06/23/2017

JCP Editors

A new prognostic indicator involving monocytes has been identified for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), according to research presented at the 22nd Congress of the European...

A new...

06/23/2017

Journal of Clinical Pathways

Research in Review

Prognostic Tools Identify High-Risk Patients With Multiple Myeloma, Predict Survival

06/22/2017

JCP Editors

Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...

...

06/22/2017

Journal of Clinical Pathways

Research in Review

Biomarker Associated With Worse Survival Outcomes in Ovarian Cancer

06/20/2017

JCP Editors

Women with advanced ovarian cancer who express a certain tumor antigen will likely experience a shorter progression-free survival (PFS) and overall survival (OS) than those without the antigen, according to research...

Women...

06/20/2017

Journal of Clinical Pathways